Yahoo · Sep 6, 2026
HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High
The medical technology company reported a notable insider sale as its shares delivered a 59% one-year return.
HT
NASDAQ · HTFL
Heartflow, Inc. Common Stock
Healthcare · Medical - Healthcare Information Services
$46.67
Down-$1.18 (-2.53%)
Updated Sep 11, 2026, 12:40 AM
SID Score
6.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.42B
- P/E ratio
- -19.76
- Dividend yield
- 0.00%
- 52-week range
- $20.13 – $51.78
- Volume
- 1.42M
- Avg. volume
- 452.7K
Price performance
HTFL price history
1M range · 0 trading sessions · Daily adjusted prices
HTFL does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest HTFL news
The latest Smart Investors Daily articles mentioning HTFL.
Stock researchCompany · Overview
HTFL research
Overview
Company profile and research snapshot.
Company profile
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $35.75
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 9, 2026 | UBS | Neutral | — |
| Aug 14, 2026 | Wells Fargo | Overweight | — |
| Aug 14, 2026 | JP Morgan | Overweight | — |
| Aug 14, 2026 | Piper Sandler | Overweight | — |
| Aug 14, 2026 | Morgan Stanley | Equal-Weight | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Sep 4, 2026
Baron SMID Cap ETF Q2 2026 Portfolio Activity
During the quarter, we initiated a position in Advanced Drainage Systems, the leading U.S. manufacturer of stormwater and onsite wastewater management products.
Yahoo · Aug 28, 2026
Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half
FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting Appropriate Use Criteria for cath lab referralsSAN FRANCISCO, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced late-breaking one-year results from an independent
Yahoo · Aug 27, 2026
Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference
SAN FRANCISCO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Wells Fargo 21st Annual Healthcare Conference. The fireside chat, which will include a slideshow presentation followed by a question-and-answer session, will take place in Boston on Wednesday, September 9, 2026, at 3:45 p.m.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
